Joongkee Min
Overview
Explore the profile of Joongkee Min including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
198
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim H, Kim H, Eom H, Choi W, Chae E, Shin H, et al.
Phys Med
. 2024 Jul;
124:103419.
PMID: 38986262
Purpose: To determine the optimal angular range (AR) for digital breast tomosynthesis (DBT) systems that provides highest lesion visibility across various breast densities and thicknesses. Method: A modular DBT phantom,...
2.
Seo J, Kim H, Min J, Kim Y, Jeon I, DLima D, et al.
J Orthop Surg Res
. 2023 Aug;
18(1):615.
PMID: 37608307
Background: The minipig has been used for research in various fields of medicine, even in orthopedics. Though previous studies have already suggested other methods to create osteoporotic bone, those methods...
3.
Jin E, Kim J, Min J, Jeon S, Choi K, Khan S, et al.
Food Sci Anim Resour
. 2023 Jul;
43(4):712-720.
PMID: 37483997
Osteoporosis is a growing global health concern primarily associated with decreased estrogen in postmenopausal women. Recently, some strains of probiotics were examined for potential anti-osteoporotic effects. This study intended to...
4.
Kwon J, Heo H, Chae Y, Min J, Lee D, Kim S, et al.
Heliyon
. 2023 May;
9(5):e15596.
PMID: 37206053
Aryl hydrocarbon receptors (AhRs) have been reported to be important mediators of ischemic injury in the brain. Furthermore, the pharmacological inhibition of AhR activation after ischemia has been shown to...
5.
Kim D, Ji W, Kim D, Choi Y, Im K, Lee C, et al.
Biochem Biophys Res Commun
. 2022 Oct;
632:85-91.
PMID: 36206598
Although epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) have shown dramatic response and improvement in treating lung cancer with mutant EGFR, the emergence of drug resistance remains a major...
6.
Choi Y, Kim D, Sung Y, Kim D, Im K, Lee H, et al.
Cancer Res
. 2022 Aug;
:OF1.
PMID: 36018295
No abstract available.
7.
Choi Y, Kim D, Sung Y, Kim D, Im K, Lee H, et al.
Cancer Res
. 2022 Aug;
:OF1.
PMID: 36006687
No abstract available.
8.
Choi Y, Kim D, Sung Y, Kim D, Im K, Lee H, et al.
Cancer Res
. 2022 Jun;
PMID: 35700239
Osimertinib is an irreversible third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that was initially developed to overcome the EGFR T790M mutation and is used as a standard...
9.
Jin E, Kim J, Yang J, Kim J, Min J, Jeon S, et al.
J Korean Neurosurg Soc
. 2021 Nov;
65(2):204-214.
PMID: 34727681
Objective: Osteoporosis result from age-related decline in the number of osteoblast progenitors in the bone marrow. Probiotics have beneficial effects on the host, when administered in appropriate amounts. This study...
10.
Jeong J, Jin E, Kim J, Min J, Jeon S, Lee M, et al.
J Orthop Res
. 2021 Aug;
40(6):1321-1328.
PMID: 34432337
The purpose of this study was to determine the efficacy of highly concentrated tricalcium phosphate (TCP) biocomposite screws on local bone formation in a rabbit model of osteoporosis induced by...